Literature DB >> 7238571

Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding.

H C Rosenberg, T H Chiu.   

Abstract

Studies were performed to evaluate the time course and possible significance of changes in specific benzodiazepine binding that occur chronic treatment. Rats were offered flurazepam in a saccharin solution as their only fluid supply. Each rats consumed 100-150 mg/kg daily. Such treatment produced no change in the binding constant (KD) of specific [3H]flunitrazepam binding. Maximal binding capacity (Bmax) was reduced by about 20% after 4 or 8 weeks of treatment, but not by 2 weeks or less. Bmax returned to control within 24 h after the end of chronic treatment. Rats were tested for susceptibility to flurazepam by injecting 20-200 mg/kg i.p., and assessing locomotor impairment. Dose-response analysis showed tolerance only after treatments and at times when Bmax was reduced. The results suggest that the reduced Bmax is an adaptive change in response to chronic benzodiazepine treatment, and that the mechanism for tolerance is a reduction of receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238571     DOI: 10.1016/0014-2999(81)90356-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.

Authors:  F Natolino; A Zanotti; A Contarino; M Lipartiti; P Giusti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 2.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.

Authors:  M Bourin; M Hascoet; B Mansouri; M C Colombel; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

Review 4.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

5.  Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.

Authors:  A Zanotti; R Mariot; A Contarino; M Lipartiti; P Giusti
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 6.  Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies.

Authors:  M Farrant; T T Gibbs; D H Farb
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

7.  Long-lasting single-dose tolerance to neurologic deficits induced by diazepam.

Authors:  S A Henauer; E J Gallaher; L E Hollister
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.

Authors:  M J Brown; D R Bristow
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Functional tolerance to lorazepam in the rat.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.